We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+8.47%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.08B
AUM Growth
+$11.4M
Cap. Flow
-$46.5M
Cap. Flow %
-4.29%
Top 10 Hldgs %
24.87%
Holding
528
New
76
Increased
75
Reduced
191
Closed
57

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$14.3M
2
ADBE icon
Adobe
ADBE
+$13.8M
3
BLK icon
Blackrock
BLK
+$11.2M
4
CMCSA icon
Comcast
CMCSA
+$10.7M
5
ABT icon
Abbott
ABT
+$9.42M

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$22.9M
2
INTC icon
Intel
INTC
+$14.9M
3
MDT icon
Medtronic
MDT
+$10.6M
4
CSCO icon
Cisco
CSCO
+$8.97M
5
AEP icon
American Electric Power
AEP
+$8.84M

Sector Composition

Rank Sector Weight
1 Technology 14.5%
2 Healthcare 9.87%
3 Financials 7.48%
4 Consumer Staples 7.27%
5 Consumer Discretionary 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEO
351
DELISTED
STORA ENSO OYJ, ADS(RP 1 SR R)
SEO
$40K ﹤0.01%
2,545
+1,545
+155% +$24.3K
AMS icon
352
American Shared Hospital Services
AMS
$10M
$39K ﹤0.01%
21,600
MELI icon
353
Mercado Libre
MELI
$98.9B
$38K ﹤0.01%
+35
New +$38K
PEBK icon
354
Peoples Bancorp of North Carolina
PEBK
$232M
$37K ﹤0.01%
2,392
RMD icon
355
ResMed
RMD
$34B
$37K ﹤0.01%
+217
New +$40.1K
BMY icon
356
Bristol-Myers Squibb
BMY
$138B
$36K ﹤0.01%
600
FPAY
357
DELISTED
FlexShopper
FPAY
$36K ﹤0.01%
20,100
PHG icon
358
Philips
PHG
$26.4B
$36K ﹤0.01%
952
-417
-30% -$16.7K
TSM icon
359
TSMC
TSM
$2.17T
$36K ﹤0.01%
438
-450
-51% -$34.2K
TRLV
360
Trulieve Cannabis Corp
TRLV
$2.2B
$36K ﹤0.01%
1,943
+648
+50% +$12K
FMS icon
361
Fresenius Medical Care
FMS
$12.5B
$33K ﹤0.01%
777
-340
-30% -$14.7K
ABBV icon
362
AbbVie
ABBV
$465B
$32K ﹤0.01%
+369
New +$34.7K
EC icon
363
Ecopetrol
EC
$34B
$31K ﹤0.01%
3,100
-57,095
-95% -$649K
GFI icon
364
Gold Fields
GFI
$42.6B
$31K ﹤0.01%
+2,552
New +$31.4K
LUMN icon
365
Lumen
LUMN
$6.28B
$31K ﹤0.01%
3,140
+2,200
+234% +$22.9K
TAYD icon
366
Taylor Devices
TAYD
$194M
$31K ﹤0.01%
3,260
TRT
367
Trio-Tech International
TRT
$104M
$31K ﹤0.01%
18,300
NICE icon
368
Nice
NICE
$5.92B
$30K ﹤0.01%
+131
New +$27.9K
PSX icon
369
Phillips 66
PSX
$96.7B
$30K ﹤0.01%
578
-10,832
-95% -$661K
AWI icon
370
Armstrong World Industries
AWI
$7.51B
$28K ﹤0.01%
+405
New +$29.6K
EPOL icon
371
iShares MSCI Poland ETF
EPOL
$866M
$28K ﹤0.01%
1,685
MTCH icon
372
Match Group
MTCH
$9.66B
$28K ﹤0.01%
+255
New +$27K
TLF icon
373
Tandy Leather Factory
TLF
$21.3M
$27K ﹤0.01%
8,424
PFIN
374
DELISTED
P&F Industries
PFIN
$27K ﹤0.01%
6,150
DOC
375
DELISTED
PHYSICIANS REALTY TRUST
DOC
$27K ﹤0.01%
1,500

Similar funds

James Investment Research's Q3 2020 Portfolio in Review

As of Q3 2020, James Investment Research held 528 positions worth $1.08B, up 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

James Investment Research withdrew a net $46.5M in Q3 2020, closing 57 positions and reducing 191 holdings. Its most notable exit was iShares Gold Trust, an estimated $22.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, James Investment Research opened a new position in Mastercard worth $14.9M.

  • James Investment Research's largest Q3 2020 buy was Mastercard: 43,948 shares worth $14.9M.
  • James Investment Research added most to Comcast in Q3 2020, an estimated $10.7M increase.
  • James Investment Research's biggest Q3 2020 reduction was Intel, cutting an estimated $14.9M.
  • James Investment Research fully exited iShares Gold Trust in Q3 2020, selling an estimated $22.9M.
  • James Investment Research's ten largest holdings make up 25% of its $1.08B portfolio in Q3 2020.
  • James Investment Research opened 76 new positions and closed 57 in Q3 2020.
  • James Investment Research's portfolio value rose 1.1% quarter-over-quarter to $1.08B.

Based on James Investment Research's 13F filing for Q3 2020, filed 23 Oct 2020.